Katalin Kariko

Katalin Kariko is a Hungarian-American biochemist and Adjunct Professor of Neurosurgery at the University of Pennsylvania's Perelman School of Medicine, holding a part-time academic position while serving as Senior Vice President at BioNTech. Her career spans over three decades of pioneering mRNA research.

Her research focuses on mRNA therapeutics, vaccine development, and RNA biology with emphasis on nucleoside modifications to overcome immunogenicity barriers. Kariko's foundational work enabled the creation of mRNA vaccine platforms that achieved global impact during the COVID-19 pandemic through rapid development and deployment.

Major scientific recognitions include:

• Nobel Prize in Physiology or Medicine (2023)
• Breakthrough Prize in Life Sciences (2021)
• Lasker-DeBakey Clinical Medical Research Award (2021)
• Cameron Prize for Therapeutics of the University of Edinburgh (2021)

Kariko's career exemplifies perseverance in basic science, having advanced mRNA technology through decades of skepticism and funding challenges before its transformative medical applications. Her work continues to drive next-generation vaccine and therapeutic development at BioNTech while maintaining academic collaboration through her UPenn affiliation.